Evidence map›Paper›PMID 31564977›Full record

ArticleCancer management and research2019

The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis.

Yan Wang, Pengfei Li, Jue Li, Yutian Lai, Kun Zhou, Xin Wang, Guowei Che

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan Wang *Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Pengfei Li *Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Jue LiDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Yutian LaiDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Kun ZhouDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Xin WangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Guowei CheDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine the predictive role of Glasgow Prognostic Score (GPS) on long-term survival in esophageal cancer.

methodComprehensive searches of electronic databases were performed to identify potential studies that evaluated the prognostic value of pretreatment GPS in esophageal cancer patients. We combined the hazard ratios (HRs) with 95% confidence intervals (CIs) to assess the association of GPS with overall survival (OS), disease-free survival (DFS) and cancer-specific survival (CSS).

resultsA total of 21 studies including 6115 patients were analyzed. Compared with patients with GPS 0, patients with elevated GPS had poorer OS (HR =2.12, 95% CI: 1.83-2.45,

conclusionPretreatment GPS could serve as a valuable factor in predicting the prognosis of patients with esophageal cancer. More well-designed prospective studies are warranted to confirm our findings.

Indexed as

esophageal cancerGlasgow Prognostic Scoremeta-analysissurvival

Identifiers

PMID31564977
PMCPMC6732518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.